Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Levemir

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2020
Review
2020
Abstract BACKGROUND: Opdivo, or Nivolumab is an immunotherapy medication that works as a checkpoint inhibitor. It is used in… Expand
Is this relevant?
Review
2016
Review
2016
The effectiveness of a drug is dependent on accumulation at the site of action at therapeutic levels, however, challenges such as… Expand
  • figure 1
  • figure 2
  • table 1
Is this relevant?
2016
2016
Keyword : Profil Peresepan, Antidiabetes, Rawat Jalan ABSTRAK Diabetes Mellitus (DM) merupakan suatu kelompok penyakit… Expand
Is this relevant?
2015
2015
to conduct analysis of basal-bolus insulin detemir/aspart in comparison with the NPH/human insulin for the treatment of patients… Expand
Is this relevant?
Highly Cited
2012
Highly Cited
2012
AIMS The aim of this analysis is to determine the timing of insulin initiation in routine clinical practice, especially in… Expand
  • table 2
  • figure 1
  • table 3
  • table 4
Is this relevant?
Review
2012
Review
2012
There is an association between insulin analogues, glargine, lispro and aspart and the incidence of malignancies. A 76 year-old… Expand
Is this relevant?
2006
2006
  • The Medical letter on drugs and therapeutics
  • 2006
  • Corpus ID: 354205
The second basal insulin analog for type 1 and type 2 diabetes. How does it compare to NPH? And to glargine (Lantus). 
Is this relevant?
Review
2006
Review
2006
Insulin detemir (Levemir) is a soluble long-acting human insulin analogue acylated with a 14-carbon fatty acid. Insulin detemir… Expand
Is this relevant?
Review
2006
Review
2006
Insulin detemir (Levemir) is a soluble long-acting human insulin analogue acylated with a 14-carbon fatty acid. Insulin detemir… Expand
Is this relevant?